From planta to pharma with glycosylation in the toolbox

Plant-specific glycosylation has long been a major limitation to the extensive use of plant-made pharmaceuticals in human therapy. Our goal here is to highlight the progress recently made towards humanization of N -glycosylation in plants and to illustrate that plant-typical N - and O -glycosylation...

Full description

Saved in:
Bibliographic Details
Published inTrends in biotechnology (Regular ed.) Vol. 25; no. 7; pp. 317 - 323
Main Authors Saint-Jore-Dupas, Claude, Faye, Loïc, Gomord, Véronique
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.07.2007
Elsevier Science
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Plant-specific glycosylation has long been a major limitation to the extensive use of plant-made pharmaceuticals in human therapy. Our goal here is to highlight the progress recently made towards humanization of N -glycosylation in plants and to illustrate that plant-typical N - and O -glycosylation progressively emerge as additional advantages for using this promising expression system.
Bibliography:http://dx.doi.org/10.1016/j.tibtech.2007.04.008
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0167-7799
1879-3096
DOI:10.1016/j.tibtech.2007.04.008